Glaxosmithkline Share News (GSK)

DIRECTOR DEALINGS: Glaxo Executives Acquire Shares

LONDON (Alliance News) - Glaxosmithkline PLC Wednesday said senior executives, including Chief Executive Andrew Witty and Chief Financial Officer Simon Dingermans, acquired shares under the company share reward plan at a price of 1631.63 pence Monday.

Details are as follows.
Read more

UK Dividends Calendar - Week Ahead

Read more 11 Feb 2014 16:36 DIRECTOR DEALINGS: Glaxo Divisional VP Exercises Options, Sells Shares LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said Simon Bicknall, a divisional vice president, exercised options over 12,650 shares at an exercise price of GBP11.23 per share and sold the shares at GBP16 each Monday. Shares in the healthcare company were up 2.0% at 1,640.09 pence Tu Read more 11 Feb 2014 15:17 FDA to review possible heart risks with AstraZeneca's diabetes drug Feb 11 (Reuters) - The U.S. Food and Drug Administration said it will review possible heart risks associated with AstraZeneca Plc's widely-used diabetes drug saxagliptin, marketed as Onglyza and Kombiglyze XR. The health regulator said it requested for data from clinical trials after the Ne Read more 10 Feb 2014 19:21 DIRECTOR DEALINGS: GlaxoSmithKline CEO Gifts Shares LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that Chief Executive Officer Andrew Witty disposed of 1,800 shares as gifts in a series of transactions last Friday and on Monday. On Friday, Witty disposed of 50 shares as a gift and transferred 500 shares as a gift to one of his chi Read more 10 Feb 2014 17:42 DIRECTOR DEALINGS: GlaxoSmithKline SVP Of Human Resources Buys Shares LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that Senior Vice President of Human Resources Claire Thomas bought 33.853 shares following the purchase of shares at 1651.50 pence per share through the re-investment of dividends Friday. Shares in GlaxoSmithKline closed down 0.7% at Read more 10 Feb 2014 11:14 GSK's $1 bln share tender offer for Indian unit to start Feb 18 MUMBAI, Feb 10 (Reuters) - GlaxoSmithKline Plc's (GSK) share tender offer worth $1 billion to raise its stake in the Indian unit will start on Feb 18th and end of March 5th, the manager to the offer said in a notice to the exchanges on Monday. GSK plans to raise its stake to as much as 75 Read more 7 Feb 2014 21:40 UPDATE 1-Trade groups seek more U.S. pressure on India over patent protection By Bill Berkrot Feb 7 (Reuters) - The U.S. Chamber of Commerce on Friday called on the government to ratchet up pressure on India over intellectual property rights, in a move that could help prevent Indian companies from producing cheap generic versions of medicines still under patent prote Read more 7 Feb 2014 18:27 Trade group seeks more US pressure on India over patent protection By Bill Berkrot Feb 7 (Reuters) - The U.S. Chamber of Commerce on Friday called on the government to ratchet up pressure on India over intellectual property rights, in a move that could help prevent Indian companies from producing cheap generic versions of medicines still under patent prote Read more 7 Feb 2014 09:29 STOCKS NEWS EUROPE-Shire weakens on trial failures Shares in Shire fall 1.1 percent in brisk trade after Vyvanse, a top-selling medicine for hyperactivity, fails in two late-stage clinical trials to successfully treat adults with major depressive disorders. Some traders see scope for a further near-term sell-off in Shire, up around 9 percen Read more 6 Feb 2014 16:31 FDA issues new rule to ensure safety of infant formula Feb 6 (Reuters) - The U.S. Food and Drug Administration proposed a new rule to better regulate and set safety standards in the manufacture of infant formula products. The interim final rule amends the FDA's quality control procedures, notification requirements for new formulas and changes t Read more 6 Feb 2014 13:31 2nd UPDATE: AstraZeneca 2013 Results Down, Guidance Lowered LONDON (Alliance News) - AstraZeneca PLC lowered its full-year forecast Thursday, as it saw revenue and pretax profit decline in the full year ended December 31, 2013, due to the loss of exclusivity on several of its brands and increased competition from generics. The pharmaceutical giant p Read more 6 Feb 2014 13:18 UK MIDDAY BRIEFING: Stocks Rising Again, Vodafone Leads FTSE 100 LONDON (Alliance News) - The FTSE 100 is up for a second day Thursday as the rebound from the heavy losses in equity markets in the previous five days continues, with positive reports from the likes of Vodafone and Smith & Nephew helping London's blue-chip Read more 6 Feb 2014 11:08 UPDATE 2-AstraZeneca profits heading south as patent losses bite * Low-to-mid single digit percent fall seen in 2014 sales * 2014 earnings set to drop "in the teens" * Forecast declines steeper than market expected * Q4 sales $6.84 bln vs consensus $6.88 bln * Q4 core earnings per share $1.23 vs consensus $1.16 By Ben HirschlerRead more 285286287288289290291292293 Stay Informed! With our newsletters and social media channels. Daily Market Report (Weekday Evenings)Week Ahead (Sunday Evening) Login to your account Login failed Remember MeSign In Don't have an account? Click here to register. Quickpicks are a member only feature Login to your account Login failed Remember MeSign In Don't have an account? Click here to register.